| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
SC 13D/A
| Shendelman Shoshana reports a 13.3% stake in APPLIED THERAPEUTICS, INC. |
| 01/13/2023 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Sold 15,870 shares
@ $0.91, valued at
$14.4k
Granted 1,964,362 shares
@ $0 |
|
| 10/14/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Bought 50,000 shares
@ $0.645, valued at
$32.3k
|
|
| 10/14/2022 |
SC 13D/A
| Shendelman Shoshana reports a 14.9% stake in APPLIED THERAPEUTICS, INC. |
| 10/13/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Bought 73,256 shares
@ $0.5582, valued at
$40.9k
|
|
| 10/12/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Bought 38,153 shares
@ $0.5227, valued at
$19.9k
|
|
| 08/04/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Disposed/sold 234,616 options to buy
@ $3.33, valued at
$781.3k
Disposed/sold 234,616 options to buy
@ $1.05, valued at
$246.3k
Disposed/sold 101,670 options to buy
@ $23.15, valued at
$2.4M
Disposed/sold 101,670 options to buy
@ $1.05, valued at
$106.8k
Disposed/sold 134,979 options to buy
@ $22.2, valued at
$3M
Disposed/sold 134,979 options to buy
@ $1.05, valued at
$141.7k
Disposed/sold 23,317 options to buy
@ $22.2, valued at
$517.6k
Disposed/sold 23,317 options to buy
@ $1.05, valued at
$24.5k
Disposed/sold 607,484 options to buy
@ $10, valued at
$6.1M
Disposed/sold 607,484 options to buy
@ $1.05, valued at
$637.9k
|
|
| 01/28/2022 |
SC 13D/A
| Shendelman Shoshana reports a 25% stake in APPLIED THERAPEUTICS, INC. |
| 01/27/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 234,616 options to buy
@ $3.33, valued at
$781.3k
|
|
| 01/11/2022 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 120,900 shares
@ $0
Granted 80,600 options to buy
@ $4.17, valued at
$336.1k
|
|
| 01/11/2022 |
4/A
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 120,900 shares
@ $0 |
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
5
| Shendelman Shoshana (President and CEO) has filed a Form 5 on Applied Therapeutics Inc. |
| 12/14/2020 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 256,850 options to buy
@ $23.15, valued at
$5.9M
|
|
| 11/13/2020 |
3
| Shendelman Shoshana (Director) has filed a Form 3 on 180 Life Sciences Corp. |
| 08/14/2020 |
SC 13D/A
| Shendelman Shoshana reports a 26.5% stake in APPLIED THERAPEUTICS, INC. |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Gifted 290,280 shares
@ $0
Gifted 709,720 shares
@ $0
Gifted 290,280 shares
@ $0
Gifted 709,720 shares
@ $0
Sold 125,000 shares
@ $42.7, valued at
$5.3M
Exercised 27,624 options to buy
@ $1, valued at
$27.6k
Exercised 97,376 options to buy
@ $1.44, valued at
$140.2k
|
|
| 06/01/2020 |
SC 13D/A
| Shendelman Shoshana reports a 27% stake in APPLIED THERAPEUTICS, INC. |
| 02/14/2020 |
5
| Shendelman Shoshana (President and CEO) has filed a Form 5 on Applied Therapeutics Inc. |
| 12/18/2019 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 209,000 options to buy
@ $22.2, valued at
$4.6M
Granted 23,317 options to buy
@ $22.2, valued at
$517.6k
|
|
| 05/29/2019 |
4/A
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Converted 88,397 shares
@ $0
Converted 88,397 preferred shares
@ $0 |
|
| 05/29/2019 |
3/A
| Shendelman Shoshana (President and CEO) has filed a Form 3/A on Applied Therapeutics Inc. |
| 05/29/2019 |
SC 13D
| Shendelman Shoshana reports a 32.4% stake in APPLIED THERAPEUTICS, INC. |
| 05/20/2019 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Bought 125,000 shares
@ $10, valued at
$1.3M
|
|
| 05/15/2019 |
4
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 767,349 options to buy
@ $10, valued at
$7.7M
|
|
| 05/13/2019 |
3
| Shendelman Shoshana (President and CEO) has filed a Form 3 on Applied Therapeutics Inc. |